Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Indivior Pharmaceuticals Inc. (INDV) had Revenue of $317.00M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$317.00M
Net Income	$89.00M
Cost of Goods Sold	$40.00M
Gross Profit	$277.00M
Operating Expenses	$180.00M
Operating Income	$137.00M
Non-Operating Income/Expense	$-22.00M
Pre-Tax Income	$115.00M
Normalized Pre-Tax Income	$115.00M
Income after Taxes	$89.00M
Income from Continuous Operations	$89.00M
Consolidated Net Income/Loss	$89.00M
Normalized Income after Taxes	$89.00M
EBIT	$137.00M
EBITDA	$141.00M
Weighted-Average Shares Outstanding (Basic)	124.00M
Weighted-Average Shares Outstanding (Diluted)	129.00M
Earnings per Share (EPS) (Basic)	$0.71
Earnings per Share (EPS) (Diluted)	$0.69
Balance Sheet Financials
Current Assets	$667.00M
Property, Plant, and Equipment	$157.00M
Long-Term Assets	$530.00M
Total Assets	$1.20B
Current Liabilities	$779.00M
Long-Term Debt	$486.00M
Long-Term Liabilities	$562.00M
Total Liabilities	$1.34B
Common Equity	$-144.00M
Tangible Shareholders Equity	$-146.00M
Shareholders Equity	$-144.00M
Common Shares Outstanding	125.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-9.00M
Cash Flow from Investing Activities	$-19.00M
Cash Flow from Financial Activities	$7.00M
Beginning Cash	$195.00M
End Cash	$175.00M
Increase/Decrease in Cash	$-20.00M
Stock-Based Compensation	$9.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.86
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.42
Debt to Equity Ratio	-3.38
Gross Margin	87.38%
Operating Margin	43.22%
EBIT Margin	43.22%
EBITDA Margin	--
Pre-Tax Profit Margin	36.28%
Profit Margin	28.08%
Free Cash Flow	$-29.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	0.26
Receiveable Turnover	1.11
Days Sales in Receivables	80.91
Return on Equity	-61.81%
Return on Tangible Equity	-60.96%
Return on Assets	7.44%
Return on Investments	26.02%
Book Value Per Share	$-1.15
Free Cash Flow per Share	$-0.22
Operating Cash Flow per Share	$-0.07

Data from Zacks Investment Research, Inc.